MENU
CNCR
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

Range Cancer Therapeutics ETF (CNCR) Ownership - Who owns Range Cancer Therapeutics ETF?

The investment seeks to track the performance, before fees and expenses, of the Range Oncology Therapeutics Index... Show more

Category: #Health

Profile

Category
Health
Address
ETF Series Solutions615 East Michigan Street, Milwaukee, WisconsinEast Michigan
Phone
(414) 765-5586
Web
N/A

Details

Group
Domestic Stock Funds
Category
Health
Net Assets
7260551.00
Fund Existence
over 9 years
Turnover
52.00
Capitalization
N/A
Yield
N/A
Total Expense Ratio
0.79
Investment Style
N/A
Risk (Beta)
0.92

Fundamentals

CNCR
Net Assets
7.26M
Yield
0.00
Fund Existence
over 9 years
Total Expense Ratio
0.79
Turnover
52.00
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
0.92
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
0.79
Assets in Top Ten Holdings
4.2M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
7.26M
Fund Type
ETF
Index Fund
Yes
Management Fee
0.79
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
76.00
Number of Net Holdings
77.00
Number of Short Holdings
1.00
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
26.68%
Gain YTD
-27.539
View a ticker or compare two or three
CNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
ETF Series Solutions615 East Michigan Street, Milwaukee, WisconsinEast Michigan
Phone
(414) 765-5586
Web
N/A